Cargando…

Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide

BACKGROUND: We have previously used a unique mouse monoclonal antibody cmHsp70.1 to demonstrate the selective presence of a membrane-bound form of Hsp70 (memHsp70) on a variety of leukemia cells and on single cell suspensions derived from solid tumors of different entities, but not on non-transforme...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehrmann, Mathias, Stangl, Stefan, Foulds, Gemma A., Oellinger, Rupert, Breuninger, Stephanie, Rad, Roland, Pockley, Alan G., Multhoff, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148261/
https://www.ncbi.nlm.nih.gov/pubmed/25165986
http://dx.doi.org/10.1371/journal.pone.0105344
_version_ 1782332588925386752
author Gehrmann, Mathias
Stangl, Stefan
Foulds, Gemma A.
Oellinger, Rupert
Breuninger, Stephanie
Rad, Roland
Pockley, Alan G.
Multhoff, Gabriele
author_facet Gehrmann, Mathias
Stangl, Stefan
Foulds, Gemma A.
Oellinger, Rupert
Breuninger, Stephanie
Rad, Roland
Pockley, Alan G.
Multhoff, Gabriele
author_sort Gehrmann, Mathias
collection PubMed
description BACKGROUND: We have previously used a unique mouse monoclonal antibody cmHsp70.1 to demonstrate the selective presence of a membrane-bound form of Hsp70 (memHsp70) on a variety of leukemia cells and on single cell suspensions derived from solid tumors of different entities, but not on non-transformed cells or cells from corresponding ’healthy‘ tissue. This antibody can be used to image tumors in vivo and target them for antibody-dependent cellular cytotoxicity. Tumor-specific expression of memHsp70 therefore has the potential to be exploited for theranostic purposes. Given the advantages of peptides as imaging and targeting agents, this study assessed whether a 14-mer tumor penetrating peptide (TPP; TKDNNLLGRFELSG), the sequence of which is derived from the oligomerization domain of Hsp70 which is expressed on the cell surface of tumor cells, can also be used for targeting membrane Hsp70 positive (memHsp70+) tumor cells, in vitro. METHODOLOGY/PRINCIPAL FINDINGS: The specificity of carboxy-fluorescein (CF-) labeled TPP (TPP) to Hsp70 was proven in an Hsp70 knockout mammary tumor cell system. TPP specifically binds to different memHsp70+ mouse and human tumor cell lines and is rapidly taken up via endosomes. Two to four-fold higher levels of CF-labeled TPP were detected in MCF7 (82% memHsp70+) and MDA-MB-231 (75% memHsp70+) cells compared to T47D cells (29% memHsp70+) that exhibit a lower Hsp70 membrane positivity. After 90 min incubation, TPP co-localized with mitochondrial membranes in memHsp70+ tumors. Although there was no evidence that any given vesicle population was specifically localized, fluorophore-labeled cmHsp70.1 antibody and TPP preferentially accumulated in the proximity of the adherent surface of cultured cells. These findings suggest a potential association between membrane Hsp70 expression and cytoskeletal elements that are involved in adherence, the establishment of intercellular synapses and/or membrane reorganization. CONCLUSIONS/SIGNIFICANCE: This study demonstrates the specific binding and rapid internalization of TPP by tumor cells with a memHsp70+ phenotype. TPP might therefore have potential for targeting and imaging the large proportion of tumors (∼50%) that express memHsp70.
format Online
Article
Text
id pubmed-4148261
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41482612014-08-29 Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide Gehrmann, Mathias Stangl, Stefan Foulds, Gemma A. Oellinger, Rupert Breuninger, Stephanie Rad, Roland Pockley, Alan G. Multhoff, Gabriele PLoS One Research Article BACKGROUND: We have previously used a unique mouse monoclonal antibody cmHsp70.1 to demonstrate the selective presence of a membrane-bound form of Hsp70 (memHsp70) on a variety of leukemia cells and on single cell suspensions derived from solid tumors of different entities, but not on non-transformed cells or cells from corresponding ’healthy‘ tissue. This antibody can be used to image tumors in vivo and target them for antibody-dependent cellular cytotoxicity. Tumor-specific expression of memHsp70 therefore has the potential to be exploited for theranostic purposes. Given the advantages of peptides as imaging and targeting agents, this study assessed whether a 14-mer tumor penetrating peptide (TPP; TKDNNLLGRFELSG), the sequence of which is derived from the oligomerization domain of Hsp70 which is expressed on the cell surface of tumor cells, can also be used for targeting membrane Hsp70 positive (memHsp70+) tumor cells, in vitro. METHODOLOGY/PRINCIPAL FINDINGS: The specificity of carboxy-fluorescein (CF-) labeled TPP (TPP) to Hsp70 was proven in an Hsp70 knockout mammary tumor cell system. TPP specifically binds to different memHsp70+ mouse and human tumor cell lines and is rapidly taken up via endosomes. Two to four-fold higher levels of CF-labeled TPP were detected in MCF7 (82% memHsp70+) and MDA-MB-231 (75% memHsp70+) cells compared to T47D cells (29% memHsp70+) that exhibit a lower Hsp70 membrane positivity. After 90 min incubation, TPP co-localized with mitochondrial membranes in memHsp70+ tumors. Although there was no evidence that any given vesicle population was specifically localized, fluorophore-labeled cmHsp70.1 antibody and TPP preferentially accumulated in the proximity of the adherent surface of cultured cells. These findings suggest a potential association between membrane Hsp70 expression and cytoskeletal elements that are involved in adherence, the establishment of intercellular synapses and/or membrane reorganization. CONCLUSIONS/SIGNIFICANCE: This study demonstrates the specific binding and rapid internalization of TPP by tumor cells with a memHsp70+ phenotype. TPP might therefore have potential for targeting and imaging the large proportion of tumors (∼50%) that express memHsp70. Public Library of Science 2014-08-28 /pmc/articles/PMC4148261/ /pubmed/25165986 http://dx.doi.org/10.1371/journal.pone.0105344 Text en © 2014 Gehrmann et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gehrmann, Mathias
Stangl, Stefan
Foulds, Gemma A.
Oellinger, Rupert
Breuninger, Stephanie
Rad, Roland
Pockley, Alan G.
Multhoff, Gabriele
Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
title Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
title_full Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
title_fullStr Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
title_full_unstemmed Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
title_short Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
title_sort tumor imaging and targeting potential of an hsp70-derived 14-mer peptide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148261/
https://www.ncbi.nlm.nih.gov/pubmed/25165986
http://dx.doi.org/10.1371/journal.pone.0105344
work_keys_str_mv AT gehrmannmathias tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT stanglstefan tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT fouldsgemmaa tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT oellingerrupert tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT breuningerstephanie tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT radroland tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT pockleyalang tumorimagingandtargetingpotentialofanhsp70derived14merpeptide
AT multhoffgabriele tumorimagingandtargetingpotentialofanhsp70derived14merpeptide